Self-Monitoring Blood Glucose System-EMEA Market Status and Trend Report 2013-2023
Report Summary
Self-Monitoring Blood Glucose System-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Self-Monitoring Blood Glucose System industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Self-Monitoring Blood Glucose System 2013-2017, and development forecast 2018-2023
Main market players of Self-Monitoring Blood Glucose System in EMEA, with company and product introduction, position in the Self-Monitoring Blood Glucose System market
Market status and development trend of Self-Monitoring Blood Glucose System by types and applications
Cost and profit status of Self-Monitoring Blood Glucose System, and marketing status
Market growth drivers and challenges
The report segments the EMEA Self-Monitoring Blood Glucose System market as:
EMEA Self-Monitoring Blood Glucose System Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Self-Monitoring Blood Glucose System Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Blood Glucose meters
Testing strips
Lancets & Lancing Devices
EMEA Self-Monitoring Blood Glucose System Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Type 2 Diabetes
Type 1 Diabetes
Gestational Diabetes
EMEA Self-Monitoring Blood Glucose System Market: Players Segment Analysis (Company and Product introduction, Self-Monitoring Blood Glucose System Sales Volume, Revenue, Price and Gross Margin):
Roche (Switzerland)
Abbott (US)
LifeScan (US)
Ascensia (Switzerland)
Medtronic (Ireland), Dexcom (US)
Ypsomed (Switzerland)
B. Braun (Germany)
Nipro (Japan), Sanofi (France)
ARKRAY (Japan)
Prodigy Diabetes Care (US)
ACON Laboratories (US)
Nova Biomedical (US)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Self-Monitoring Blood Glucose System-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Self-Monitoring Blood Glucose System industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Self-Monitoring Blood Glucose System 2013-2017, and development forecast 2018-2023
Main market players of Self-Monitoring Blood Glucose System in EMEA, with company and product introduction, position in the Self-Monitoring Blood Glucose System market
Market status and development trend of Self-Monitoring Blood Glucose System by types and applications
Cost and profit status of Self-Monitoring Blood Glucose System, and marketing status
Market growth drivers and challenges
The report segments the EMEA Self-Monitoring Blood Glucose System market as:
EMEA Self-Monitoring Blood Glucose System Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Self-Monitoring Blood Glucose System Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Blood Glucose meters
Testing strips
Lancets & Lancing Devices
EMEA Self-Monitoring Blood Glucose System Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Type 2 Diabetes
Type 1 Diabetes
Gestational Diabetes
EMEA Self-Monitoring Blood Glucose System Market: Players Segment Analysis (Company and Product introduction, Self-Monitoring Blood Glucose System Sales Volume, Revenue, Price and Gross Margin):
Roche (Switzerland)
Abbott (US)
LifeScan (US)
Ascensia (Switzerland)
Medtronic (Ireland), Dexcom (US)
Ypsomed (Switzerland)
B. Braun (Germany)
Nipro (Japan), Sanofi (France)
ARKRAY (Japan)
Prodigy Diabetes Care (US)
ACON Laboratories (US)
Nova Biomedical (US)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF SELF-MONITORING BLOOD GLUCOSE SYSTEM
1.1 Definition of Self-Monitoring Blood Glucose System in This Report
1.2 Commercial Types of Self-Monitoring Blood Glucose System
1.2.1 Blood Glucose meters
1.2.2 Testing strips
1.2.3 Lancets & Lancing Devices
1.3 Downstream Application of Self-Monitoring Blood Glucose System
1.3.1 Type 2 Diabetes
1.3.2 Type 1 Diabetes
1.3.3 Gestational Diabetes
1.4 Development History of Self-Monitoring Blood Glucose System
1.5 Market Status and Trend of Self-Monitoring Blood Glucose System 2013-2023
1.5.1 EMEA Self-Monitoring Blood Glucose System Market Status and Trend 2013-2023
1.5.2 Regional Self-Monitoring Blood Glucose System Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Self-Monitoring Blood Glucose System in EMEA 2013-2017
2.2 Consumption Market of Self-Monitoring Blood Glucose System in EMEA by Regions
2.2.1 Consumption Volume of Self-Monitoring Blood Glucose System in EMEA by Regions
2.2.2 Revenue of Self-Monitoring Blood Glucose System in EMEA by Regions
2.3 Market Analysis of Self-Monitoring Blood Glucose System in EMEA by Regions
2.3.1 Market Analysis of Self-Monitoring Blood Glucose System in Europe 2013-2017
2.3.2 Market Analysis of Self-Monitoring Blood Glucose System in Middle East 2013-2017
2.3.3 Market Analysis of Self-Monitoring Blood Glucose System in Africa 2013-2017
2.4 Market Development Forecast of Self-Monitoring Blood Glucose System in EMEA 2018-2023
2.4.1 Market Development Forecast of Self-Monitoring Blood Glucose System in EMEA 2018-2023
2.4.2 Market Development Forecast of Self-Monitoring Blood Glucose System by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Self-Monitoring Blood Glucose System in EMEA by Types
3.1.2 Revenue of Self-Monitoring Blood Glucose System in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Self-Monitoring Blood Glucose System in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Self-Monitoring Blood Glucose System in EMEA by Downstream Industry
4.2 Demand Volume of Self-Monitoring Blood Glucose System by Downstream Industry in Major Countries
4.2.1 Demand Volume of Self-Monitoring Blood Glucose System by Downstream Industry in Europe
4.2.2 Demand Volume of Self-Monitoring Blood Glucose System by Downstream Industry in Middle East
4.2.3 Demand Volume of Self-Monitoring Blood Glucose System by Downstream Industry in Africa
4.3 Market Forecast of Self-Monitoring Blood Glucose System in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE SYSTEM
5.1 EMEA Economy Situation and Trend Overview
5.2 Self-Monitoring Blood Glucose System Downstream Industry Situation and Trend Overview
CHAPTER 6 SELF-MONITORING BLOOD GLUCOSE SYSTEM MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Self-Monitoring Blood Glucose System in EMEA by Major Players
6.2 Revenue of Self-Monitoring Blood Glucose System in EMEA by Major Players
6.3 Basic Information of Self-Monitoring Blood Glucose System by Major Players
6.3.1 Headquarters Location and Established Time of Self-Monitoring Blood Glucose System Major Players
6.3.2 Employees and Revenue Level of Self-Monitoring Blood Glucose System Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 SELF-MONITORING BLOOD GLUCOSE SYSTEM MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Roche (Switzerland)
7.1.1 Company profile
7.1.2 Representative Self-Monitoring Blood Glucose System Product
7.1.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Roche (Switzerland)
7.2 Abbott (US)
7.2.1 Company profile
7.2.2 Representative Self-Monitoring Blood Glucose System Product
7.2.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Abbott (US)
7.3 LifeScan (US)
7.3.1 Company profile
7.3.2 Representative Self-Monitoring Blood Glucose System Product
7.3.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of LifeScan (US)
7.4 Ascensia (Switzerland)
7.4.1 Company profile
7.4.2 Representative Self-Monitoring Blood Glucose System Product
7.4.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Ascensia (Switzerland)
7.5 Medtronic (Ireland), Dexcom (US)
7.5.1 Company profile
7.5.2 Representative Self-Monitoring Blood Glucose System Product
7.5.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Medtronic (Ireland), Dexcom (US)
7.6 Ypsomed (Switzerland)
7.6.1 Company profile
7.6.2 Representative Self-Monitoring Blood Glucose System Product
7.6.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Ypsomed (Switzerland)
7.7 B. Braun (Germany)
7.7.1 Company profile
7.7.2 Representative Self-Monitoring Blood Glucose System Product
7.7.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of B. Braun (Germany)
7.8 Nipro (Japan), Sanofi (France)
7.8.1 Company profile
7.8.2 Representative Self-Monitoring Blood Glucose System Product
7.8.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Nipro (Japan), Sanofi (France)
7.9 ARKRAY (Japan)
7.9.1 Company profile
7.9.2 Representative Self-Monitoring Blood Glucose System Product
7.9.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of ARKRAY (Japan)
7.10 Prodigy Diabetes Care (US)
7.10.1 Company profile
7.10.2 Representative Self-Monitoring Blood Glucose System Product
7.10.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Prodigy Diabetes Care (US)
7.11 ACON Laboratories (US)
7.11.1 Company profile
7.11.2 Representative Self-Monitoring Blood Glucose System Product
7.11.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of ACON Laboratories (US)
7.12 Nova Biomedical (US)
7.12.1 Company profile
7.12.2 Representative Self-Monitoring Blood Glucose System Product
7.12.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Nova Biomedical (US)
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE SYSTEM
8.1 Industry Chain of Self-Monitoring Blood Glucose System
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE SYSTEM
9.1 Cost Structure Analysis of Self-Monitoring Blood Glucose System
9.2 Raw Materials Cost Analysis of Self-Monitoring Blood Glucose System
9.3 Labor Cost Analysis of Self-Monitoring Blood Glucose System
9.4 Manufacturing Expenses Analysis of Self-Monitoring Blood Glucose System
CHAPTER 10 MARKETING STATUS ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE SYSTEM
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Self-Monitoring Blood Glucose System in This Report
1.2 Commercial Types of Self-Monitoring Blood Glucose System
1.2.1 Blood Glucose meters
1.2.2 Testing strips
1.2.3 Lancets & Lancing Devices
1.3 Downstream Application of Self-Monitoring Blood Glucose System
1.3.1 Type 2 Diabetes
1.3.2 Type 1 Diabetes
1.3.3 Gestational Diabetes
1.4 Development History of Self-Monitoring Blood Glucose System
1.5 Market Status and Trend of Self-Monitoring Blood Glucose System 2013-2023
1.5.1 EMEA Self-Monitoring Blood Glucose System Market Status and Trend 2013-2023
1.5.2 Regional Self-Monitoring Blood Glucose System Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Self-Monitoring Blood Glucose System in EMEA 2013-2017
2.2 Consumption Market of Self-Monitoring Blood Glucose System in EMEA by Regions
2.2.1 Consumption Volume of Self-Monitoring Blood Glucose System in EMEA by Regions
2.2.2 Revenue of Self-Monitoring Blood Glucose System in EMEA by Regions
2.3 Market Analysis of Self-Monitoring Blood Glucose System in EMEA by Regions
2.3.1 Market Analysis of Self-Monitoring Blood Glucose System in Europe 2013-2017
2.3.2 Market Analysis of Self-Monitoring Blood Glucose System in Middle East 2013-2017
2.3.3 Market Analysis of Self-Monitoring Blood Glucose System in Africa 2013-2017
2.4 Market Development Forecast of Self-Monitoring Blood Glucose System in EMEA 2018-2023
2.4.1 Market Development Forecast of Self-Monitoring Blood Glucose System in EMEA 2018-2023
2.4.2 Market Development Forecast of Self-Monitoring Blood Glucose System by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Self-Monitoring Blood Glucose System in EMEA by Types
3.1.2 Revenue of Self-Monitoring Blood Glucose System in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Self-Monitoring Blood Glucose System in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Self-Monitoring Blood Glucose System in EMEA by Downstream Industry
4.2 Demand Volume of Self-Monitoring Blood Glucose System by Downstream Industry in Major Countries
4.2.1 Demand Volume of Self-Monitoring Blood Glucose System by Downstream Industry in Europe
4.2.2 Demand Volume of Self-Monitoring Blood Glucose System by Downstream Industry in Middle East
4.2.3 Demand Volume of Self-Monitoring Blood Glucose System by Downstream Industry in Africa
4.3 Market Forecast of Self-Monitoring Blood Glucose System in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE SYSTEM
5.1 EMEA Economy Situation and Trend Overview
5.2 Self-Monitoring Blood Glucose System Downstream Industry Situation and Trend Overview
CHAPTER 6 SELF-MONITORING BLOOD GLUCOSE SYSTEM MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Self-Monitoring Blood Glucose System in EMEA by Major Players
6.2 Revenue of Self-Monitoring Blood Glucose System in EMEA by Major Players
6.3 Basic Information of Self-Monitoring Blood Glucose System by Major Players
6.3.1 Headquarters Location and Established Time of Self-Monitoring Blood Glucose System Major Players
6.3.2 Employees and Revenue Level of Self-Monitoring Blood Glucose System Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 SELF-MONITORING BLOOD GLUCOSE SYSTEM MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Roche (Switzerland)
7.1.1 Company profile
7.1.2 Representative Self-Monitoring Blood Glucose System Product
7.1.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Roche (Switzerland)
7.2 Abbott (US)
7.2.1 Company profile
7.2.2 Representative Self-Monitoring Blood Glucose System Product
7.2.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Abbott (US)
7.3 LifeScan (US)
7.3.1 Company profile
7.3.2 Representative Self-Monitoring Blood Glucose System Product
7.3.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of LifeScan (US)
7.4 Ascensia (Switzerland)
7.4.1 Company profile
7.4.2 Representative Self-Monitoring Blood Glucose System Product
7.4.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Ascensia (Switzerland)
7.5 Medtronic (Ireland), Dexcom (US)
7.5.1 Company profile
7.5.2 Representative Self-Monitoring Blood Glucose System Product
7.5.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Medtronic (Ireland), Dexcom (US)
7.6 Ypsomed (Switzerland)
7.6.1 Company profile
7.6.2 Representative Self-Monitoring Blood Glucose System Product
7.6.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Ypsomed (Switzerland)
7.7 B. Braun (Germany)
7.7.1 Company profile
7.7.2 Representative Self-Monitoring Blood Glucose System Product
7.7.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of B. Braun (Germany)
7.8 Nipro (Japan), Sanofi (France)
7.8.1 Company profile
7.8.2 Representative Self-Monitoring Blood Glucose System Product
7.8.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Nipro (Japan), Sanofi (France)
7.9 ARKRAY (Japan)
7.9.1 Company profile
7.9.2 Representative Self-Monitoring Blood Glucose System Product
7.9.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of ARKRAY (Japan)
7.10 Prodigy Diabetes Care (US)
7.10.1 Company profile
7.10.2 Representative Self-Monitoring Blood Glucose System Product
7.10.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Prodigy Diabetes Care (US)
7.11 ACON Laboratories (US)
7.11.1 Company profile
7.11.2 Representative Self-Monitoring Blood Glucose System Product
7.11.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of ACON Laboratories (US)
7.12 Nova Biomedical (US)
7.12.1 Company profile
7.12.2 Representative Self-Monitoring Blood Glucose System Product
7.12.3 Self-Monitoring Blood Glucose System Sales, Revenue, Price and Gross Margin of Nova Biomedical (US)
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE SYSTEM
8.1 Industry Chain of Self-Monitoring Blood Glucose System
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE SYSTEM
9.1 Cost Structure Analysis of Self-Monitoring Blood Glucose System
9.2 Raw Materials Cost Analysis of Self-Monitoring Blood Glucose System
9.3 Labor Cost Analysis of Self-Monitoring Blood Glucose System
9.4 Manufacturing Expenses Analysis of Self-Monitoring Blood Glucose System
CHAPTER 10 MARKETING STATUS ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE SYSTEM
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
